Atlas Trials

A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH

Clinical trial NCT03048747 · COMPLETED

Trial details

NCT number
NCT03048747
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Syndrome of Inappropriate Antidiuretic Hormone Secretion
Start date
2017-03-02
Primary completion
2019-03-19
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.